Đang chuẩn bị liên kết để tải về tài liệu:
Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The only available predictive models for the outcome of breast cancer patients in New Zealand (NZ) are based on data in other countries. We aimed to develop and validate a predictive model using NZ data for this population, and compare its performance to a widely used overseas model, the Nottingham Prognostic Index (NPI). | Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index

TÀI LIỆU LIÊN QUAN

A new method development and validation for identification and quantification of methoxyfenozide insecticide residues in grapes using high performance liquid chromatography

Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index

Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures

báo cáo khoa học:" Development, evaluation and validation of a new instrument for measurement quality of life in the parents of children with chronic disease"

báo cáo hóa học:" Development, evaluation and validation of a new instrument for measurement quality of life in the parents of children with chronic disease"

Preliminary analysis of validation evidence for two new scales assessing teachers’ confidence and worries related to delivering mental health content in the classroom

A new measure for infant mental health screening: Development and initial validation

Using gene expression from urine sediment to diagnose prostate cancer: Development of a new multiplex mRNA urine test and validation of current biomarkers

The Munich Wrist Questionnaire (MWQ) – development and validation of a new patient-reported outcome measurement tool for wrist disorders

Cathepsin-S degraded decorin are elevated in fibrotic lung disorders – development and biological validation of a new serum biomarker